Proxima Therapeutics
This article was originally published in The Gray Sheet
Executive Summary
Firm receives investigational device exemption approval to begin a five-center trial for the GliaSite catheter-based radiation therapy system for treatment of brain cancer, the Alpharetta, Georgia firm says March 11